| Company Name | Subject | Type of Action | Date of Action | Issuing Office | Product(s) | Addressee Location | File |
|---|
| Sogeval Laboratories, Inc. | CGMP regulation deviations and unapproved new drugs | UL | 3/12/2012 | Dallas District Office | topical drug products | TX | HTML PDF
|
| Merck Animal Health | Promotional Claims | UL | 4/9/2012 | CVM | NADA 141-299, Resflor Gold (florfenicol and flunixin meglumine) | NJ | HTML PDF |
| Clavel Corporation | CGMP regulation deviations and unapproved new drug | UL | 9/18/2012 | Dallas District Office | Blue Stop-E, topical pain reliever | TX | HTML PDF |
| ProCore Laboratories, LLC | CGMP regulation deviations and unapproved new drug | UL | 9/25/2012 | Dallas District Office | Douxo Chlorhexidine PS Microemulsion Spray, topical antimicrobial | TX | HTML PDF |
| Intervet Inc. (d/b/a Merck Animal Health) | Promotional Claims | UL | 10/16/2012 | CVM | NADA 141-305, Orbax (orbifloxacin) Oral Suspension | NJ | PDF |
